Gaviscon Liquid 10ml sachets Royaume-Uni - anglais - MHRA (Medicines & Healthcare Products Regulatory Agency)

gaviscon liquid 10ml sachets

reckitt benckiser healthcare (uk) ltd - sodium alginate; sodium bicarbonate; calcium carbonate - oral suspension - 50mg/1ml ; 26.7mg/1ml ; 16mg/1ml

GAVISCON LEMON TABLETS 500 500 Milligram Tablets Chewable Irlande - anglais - HPRA (Health Products Regulatory Authority)

gaviscon lemon tablets 500 500 milligram tablets chewable

reckitt benckiser ireland ltd - sodium alginate sodium bicarbonate calcium carbonate - tablets chewable - 500 milligram

GAVISCON PEPPERMINT TABLETS 500 500 Milligram Tablets Chewable Irlande - anglais - HPRA (Health Products Regulatory Authority)

gaviscon peppermint tablets 500 500 milligram tablets chewable

reckitt benckiser ireland ltd - sodium alginate sodium bicarbonate calcium carbonate - tablets chewable - 500 milligram

GAVISCON SACHETS ORAL POWDER FRESH TROPICAL FLAVOU Milligram Oral Powder Irlande - anglais - HPRA (Health Products Regulatory Authority)

gaviscon sachets oral powder fresh tropical flavou milligram oral powder

reckitt benckiser ireland ltd - sodium alginate sodium bicarbonate calcium carbonate - oral powder - milligram

SODIUM BICARBONATE injection, solution États-Unis - anglais - NLM (National Library of Medicine)

sodium bicarbonate injection, solution

mckesson corporation dba sky packaging - sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20, sodium cation - unii:lyr4m0nh37) - sodium bicarbonate 84 mg in 1 ml - sodium bicarbonate injection, usp is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. sodium bicarbonate is further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of blood pigments. sodium bicarbonate also is indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. treatment of metabolic acidosis should, if possible, be superimposed on measures designed to control the basic cause of the acidosis ― e.g., insulin in uncomplicated diabetes, blood volume restoration in shock. but since an appreciable time interval may elapse before

SODIUM BICARBONATE injection, solution États-Unis - anglais - NLM (National Library of Medicine)

sodium bicarbonate injection, solution

phebra pty ltd - sodium bicarbonate (unii: 8mdf5v39qo) (bicarbonate ion - unii:hn1zra3q20) - sodium bicarbonate 84 mg in 1 ml - sodium bicarbonate injection is indicated as an alkalinising agent in the treatment of metabolic acidosis which may occur in many conditions including diabetes, starvation, hepatitis, cardiac arrest, shock, severe dehydration, renal insufficiency, severe diarrhoea, addison's disease or administration of acidifying salts (e.g. excessive sodium chloride, calcium chloride, ammonium chloride). sodium bicarbonate injection is also used to increase urinary ph in order to increase the solubility of certain weak acids (e.g. cystine, sulphonamides, uric acid) and in the treatment of certain intoxications (e.g. methanol, phenobarbitone, salicylates, lithium) to decrease renal absorption of the drug or to correct acidosis. sodium bicarbonate injection is contraindicated in patients with renal failure, respiratory or metabolic alkalosis, hypoventilation or chloride depletion, hypernatraemia, hypertension, oedema, congestive heart failure, eclampsia, aldosteronism, a history of urinary calculi and consistent potassium dep

Phebra SODIUM BICARBONATE 8.4% w/v 840 mg/10 mL injection BP vial Australie - anglais - Department of Health (Therapeutic Goods Administration)

phebra sodium bicarbonate 8.4% w/v 840 mg/10 ml injection bp vial

phebra pty ltd - sodium bicarbonate, quantity: 84 mg/ml - injection, solution - excipient ingredients: disodium edetate; water for injections - sodium bicarbonate injection is indicated as an alkalinising agent in the treatment of metabolic acidosis which may occur in many conditions including diabetes, starvation, hepatitis, cardiac arrest, shock, severe dehydration, renal insufficiency, severe diarrhoea, addison's disease or administration of acidifying salts (e.g. excessive sodium chloride, calcium chloride, ammonium chloride). sodium bicarbonate injection is also used to increase urinary ph in order to increase the solubility of certain weak acids (e.g. cystine, sulphonamides, uric acid) and in the treatment of certain intoxications (e.g. methanol, phenobarbitone, salicylates, lithium) to decrease renal absorption of the drug or to correct acidosis.

Phebra SODIUM BICARBONATE 8.4% w/v 8.4 g/100 mL injection BP vial Australie - anglais - Department of Health (Therapeutic Goods Administration)

phebra sodium bicarbonate 8.4% w/v 8.4 g/100 ml injection bp vial

phebra pty ltd - sodium bicarbonate, quantity: 84 mg/ml - injection, solution - excipient ingredients: disodium edetate; water for injections - sodium bicarbonate injection is indicated as an alkalinising agent in the treatment of metabolic acidosis which may occur in many conditions including diabetes, starvation, hepatitis, cardiac arrest, shock, severe dehydration, renal insufficiency, severe diarrhoea, addison's disease or administration of acidifying salts (e.g. excessive sodium chloride, calcium chloride, ammonium chloride). sodium bicarbonate injection is also used to increase urinary ph in order to increase the solubility of certain weak acids (e.g. cystine, sulphonamides, uric acid) and in the treatment of certain intoxications (e.g. methanol, phenobarbitone, salicylates, lithium) to decrease renal absorption of the drug or to correct acidosis.